Skip to content

Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery

Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00491270
Enrollment
100
Registered
2007-06-26
Start date
2011-01-31
Completion date
2013-08-31
Last updated
2011-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Spontaneous, Premature Birth, Vaginosis, Bacterial

Keywords

Vaginosis, Bacterial, Abortion, Spontaneous, Premature Birth

Brief summary

To determine whether screening of pregnant women with history of previous preterm delivery or with premature contractions for bacterial vaginosis using VS-SENSE, and treatment of positive women will reduce the risk of spontaneous preterm birth.

Detailed description

This is an open-label, comparative, and prospective study. Pregnant women, pregnancy week 26 to 36+6, between the ages 18-45, who were hospitalized in the high risk department, with history of previous preterm delivery and/or with premature contractions. Patient with premature ruptured membrane will be excluded. In the hospital pregnant women with history of previous preterm delivery or with premature contractions, (participants) will be examined by speculum with no lubricant, The clinician will use the VS-SENSE to sample vaginal secretions and will immediately observe and record the color obtained.Should the VS-SENSE produce positive results the physician will consider giving clindamycin treatment.

Interventions

DEVICEVS Sense

An applicator to diagnose pH increase above 5.2

Sponsors

Common Sense
CollaboratorOTHER
Western Galilee Hospital-Nahariya
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant subjects, aged 18-45 years, pregnancy week 26 to 36+6, with history of previous preterm delivery or with premature contractions.

Exclusion criteria

* Subject with ruptured membranes. * Subject with signs and symptoms of pelvic inflammatory disease. * Subject who has used vaginal douching within 12 hours prior to arrival at the hospital. * Subject who has applied local antiseptic, antibiotic or vaginal treatment within the previous 3 days. * Subjects who have had sexual intercourse within the last 12 hours. * Subject with blood in her vaginal secretions. * Subject is currently participating in another clinical study that may directly or indirectly affect the results of this study. * Subject is unable or unwilling to cooperate with study procedures.

Design outcomes

Primary

MeasureTime frame
Does screening for BV using VS-SENSE in pregnant women with h/o preterm delivery or with premature contractions, and treatment will reduce or prevent Late miscarriage, preterm birth, preterm PROM, chorioamnionitis, and postpartum endometritis.One year

Countries

Israel

Contacts

Primary ContactJacob Bornstein, MD
+972-4-9107720

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026